secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTERPACE BIOSCIENCES, INC. (IDXG)
CIK:        0001054102
Form:       8-K/A
Filed at:   2026-08-26T14:45:11+00:00
Accession:  0001493152-26-040182
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Interpace Biosciences stockholders approve 2026 equity incentive plan and ESPP
------------------------------------------------------------------------------

- Stockholders approved 2026 Equity Incentive Plan and 2026 ESPP at Aug 20, 2026 annual meeting.
- New plans replace 2019 Equity Incentive Plan and 2019 ESPP; no further grants or purchases under old plans.
- Material terms previously disclosed in proxy statement filed July 7, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1054102/000149315226040182/0001493152-26-040182-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1054102/000149315226040182/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-040182

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer